Welcome to YLOAN.COM
yloan.com » Strategic-Planning » Zhejiang Hisun Pharmaceutical Co Ltd 600267 Financial And Strategic Analysis Review --- Aarkstore
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Zhejiang Hisun Pharmaceutical Co Ltd 600267 Financial And Strategic Analysis Review --- Aarkstore

Zhejiang Hisun Pharmaceutical Co

Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis Review

Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), a China-based public share holding company is engaged in the manufacture and sale of bulk drugs. It principally focuses in providing drugs used in antineoplastics, cardiovascular treatment, anti-infection, anti-parasite, endocrine control, immunoinhibitors and also anti-depression. The company distributes its products in domestic markets as well as overseas markets. It is highly active in research and development concentrating on chemical synthesis, microorganism fermentation, biotechnology, natural plant extraction and preparation development. Currently, Hisun owns five subsidiaries and is headquartered in Tai Zhou, China

This comprehensive SWOT profile of Zhejiang Hisun Pharmaceutical Co. Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Zhejiang Hisun Pharmaceutical Co. Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).


The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.


- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information please visit :

http://www.aarkstore.com/reports/Zhejiang-Hisun-Pharmaceutical-Co-Ltd-600267-Financial-and-Strategic-Analysis-Review-52015.html

by: Aarkstore Enterprise
Zhejiang Jingxin Pharmaceutical Co Ltd 2020 Financial And Strategic Analysis Review --- Aarkstore Tianjin Tasly Pharmaceutical Co Ltd 600535 Financial And Strategic Analysis Review --- Aarkstore Aarkstore Enterprise-suven Life Sciences Ltd. (530239) - Financial And Strategic Analysis Review Welichem Biotech Inc. (wbi) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Adeona Pharmaceuticals, Inc. (aen) - Financial And Strategic Analysis Review -- Aarkstore Enterprise Tianjin Zhongxin Pharmaceutical Group Corporation Limited (t14) - Financial And Strategic Analysis Pharmstandard (phst) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Aarkstore Enterprise - Uranium International Limited (uri) - Financial And Strategic Analysis Review Aarkstore Enterprise - Lincoln Minerals Limited (lml) - Financial And Strategic Analysis Review Aarkstore Enterprise - Oklo Uranium Limited (oku) - Financial And Strategic Analysis Review Aarkstore Enterprise - Northern Uranium Limited (ntu) - Financial And Strategic Analysis Review Aarkstore Enterprise - Rum Jungle Uranium Limited (rum) - Financial And Strategic Analysis Review Aarkstore Enterprise - Typhoon Exploration Inc. (typ) - Financial And Strategic Analysis Review
print
www.yloan.com guest:  register | login | search IP(216.73.216.125) California / Anaheim Processed in 0.216705 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 40 , 3443, 147,
Zhejiang Hisun Pharmaceutical Co Ltd 600267 Financial And Strategic Analysis Review --- Aarkstore Anaheim